O	O	0	9	Permanent	Permanent	B-NP	JJ	O	2	NMOD	O
O	O	10	19	occupancy	occupancy	I-NP	NN	O	16	SUB	O
O	O	20	22	of	of	B-PP	IN	O	2	NMOD	O
O	O	23	26	the	the	B-NP	DT	O	10	NMOD	O
T4	B-Entity	27	32	human	human	I-NP	JJ	B-DNA	10	NMOD	B-DNA
T4	I-Entity	33	49	immunodeficiency	immunodeficiency	I-NP	NN	I-DNA	10	NMOD	I-DNA
T4	I-Entity	50	55	virus	virus	I-NP	NN	I-DNA	10	NMOD	I-DNA
T4	I-Entity	56	60	type	type	I-NP	NN	I-DNA	10	NMOD	I-DNA
T4	I-Entity	61	62	1	1	I-NP	CD	I-DNA	10	NMOD	I-DNA
T4	I-Entity	63	71	enhancer	enhancer	I-NP	NN	I-DNA	3	PMOD	I-DNA
O	O	72	74	by	by	B-PP	IN	O	2	NMOD	O
T5	B-Entity	75	77	NF	NF	B-NP	NN	B-protein	15	NMOD	B-protein
T5	I-Entity	77	78	-	-	B-NP	HYPH	I-protein	15	NMOD	I-protein
T5	I-Entity	78	83	kappa	kappa	I-NP	NN	I-protein	15	NMOD	I-protein
T5	I-Entity	84	85	B	B	I-NP	NN	I-protein	11	PMOD	I-protein
O	O	86	88	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	89	95	needed	need	I-VP	VBN	O	16	VC	O
O	O	96	99	for	for	B-PP	IN	O	17	VMOD	O
O	O	100	110	persistent	persistent	B-NP	JJ	O	21	NMOD	O
O	O	111	116	viral	viral	I-NP	JJ	O	21	NMOD	O
O	O	117	128	replication	replication	I-NP	NN	O	18	PMOD	O
O	O	129	131	in	in	B-PP	IN	O	21	NMOD	O
O	O	132	141	monocytes	monocyte	B-NP	NNS	B-cell_type	22	PMOD	B-cell_type
O	O	141	142	.	.	O	.	O	16	P	O

O	O	144	148	This	This	B-NP	DT	O	2	NMOD	O
O	O	149	153	work	work	I-NP	NN	O	3	SUB	O
O	O	154	159	aimed	aim	B-VP	VBN	O	0	ROOT	O
O	O	160	162	to	to	B-VP	TO	O	5	VMOD	O
O	O	163	172	ascertain	ascertain	I-VP	VB	O	3	VMOD	O
O	O	173	176	the	the	B-NP	DT	O	7	NMOD	O
O	O	177	181	role	role	I-NP	NN	O	5	OBJ	O
O	O	182	184	of	of	B-PP	IN	O	7	NMOD	O
T6	B-Entity	185	191	kappaB	kappaB	B-NP	NN	B-DNA	12	NMOD	B-DNA
T6	I-Entity	191	192	-	-	B-NP	HYPH	I-DNA	12	NMOD	I-DNA
T6	I-Entity	192	202	responsive	responsive	I-NP	JJ	I-DNA	12	NMOD	I-DNA
T6	I-Entity	203	211	elements	element	I-NP	NNS	I-DNA	8	PMOD	I-DNA
O	O	212	214	of	of	B-PP	IN	O	12	NMOD	O
O	O	215	218	the	the	B-NP	DT	O	25	NMOD	O
T7	B-Entity	219	224	human	human	I-NP	JJ	B-DNA	25	NMOD	B-DNA
T7	I-Entity	225	241	immunodeficiency	immunodeficiency	I-NP	NN	I-DNA	25	NMOD	I-DNA
T7	I-Entity	242	247	virus	virus	I-NP	NN	I-DNA	25	NMOD	I-DNA
T7	I-Entity	248	252	type	type	I-NP	NN	I-DNA	25	NMOD	I-DNA
T7	I-Entity	253	254	1	1	I-NP	CD	I-DNA	25	NMOD	I-DNA
T7	I-Entity	255	256	(	(	O	(	I-DNA	25	NMOD	I-DNA
T7	I-Entity	256	259	HIV	HIV	O	NN	I-DNA	25	NMOD	I-DNA
T7	I-Entity	259	260	-	-	O	HYPH	I-DNA	23	P	I-DNA
T7	I-Entity	260	261	1	1	O	CD	I-DNA	25	NMOD	I-DNA
T7	I-Entity	261	262	)	)	O	)	I-DNA	25	NMOD	I-DNA
T7	I-Entity	263	271	enhancer	enhancer	B-NP	NN	I-DNA	13	PMOD	I-DNA
O	O	272	275	not	not	B-CONJP	RB	O	7	NMOD	O
O	O	276	280	only	only	I-CONJP	RB	O	26	DEP	O
O	O	281	283	in	in	B-PP	IN	O	26	PMOD	O
O	O	284	289	early	early	B-NP	JJ	O	30	NMOD	O
O	O	290	300	initiation	initiation	I-NP	NN	O	28	PMOD	O
O	O	301	304	but	but	B-CONJP	CC	O	26	PMOD	O
O	O	305	309	also	also	I-CONJP	RB	O	31	DEP	O
O	O	310	312	in	in	B-PP	IN	O	26	PMOD	O
O	O	313	317	long	long	B-NP	JJ	O	37	NMOD	O
O	O	317	318	-	-	I-NP	HYPH	O	37	NMOD	O
O	O	318	322	term	term	I-NP	NN	O	37	NMOD	O
O	O	323	334	maintenance	maintenance	I-NP	NN	O	33	PMOD	O
O	O	335	337	of	of	B-PP	IN	O	37	NMOD	O
O	O	338	346	proviral	proviral	B-NP	JJ	O	40	NMOD	O
O	O	347	360	transcription	transcription	I-NP	NN	O	38	PMOD	O
O	O	361	363	in	in	B-PP	IN	O	40	NMOD	O
O	O	364	369	cells	cell	B-NP	NNS	O	41	PMOD	O
O	O	370	372	of	of	B-PP	IN	O	42	NMOD	O
O	O	373	376	the	the	B-NP	DT	O	46	NMOD	O
O	O	377	386	monocytic	monocytic	I-NP	JJ	B-cell_type	46	NMOD	B-cell_type
O	O	387	394	lineage	lineage	I-NP	NN	I-cell_type	43	PMOD	I-cell_type
O	O	394	395	.	.	O	.	O	3	P	O

O	O	396	399	For	For	B-PP	IN	O	6	VMOD	O
O	O	400	404	this	this	B-NP	DT	O	3	NMOD	O
O	O	405	412	purpose	purpose	I-NP	NN	O	1	PMOD	O
O	O	412	413	,	,	O	,	O	6	P	O
O	O	414	416	we	we	B-NP	PRP	O	6	SUB	O
O	O	417	421	used	use	B-VP	VBD	O	0	ROOT	O
O	O	422	427	three	three	B-NP	CD	O	9	NMOD	O
O	O	428	432	main	main	I-NP	JJ	O	9	NMOD	O
O	O	433	443	approaches	approach	I-NP	NNS	O	6	OBJ	O
O	O	443	444	.	.	O	.	O	6	P	O

O	O	445	448	The	The	B-NP	DT	O	2	NMOD	O
O	O	449	454	first	first	I-NP	JJ	O	3	SUB	O
O	O	455	458	was	be	B-VP	VBD	O	0	ROOT	O
O	O	459	461	to	to	B-VP	TO	O	6	VMOD	O
O	O	462	470	abruptly	abruptly	I-VP	RB	O	6	VMOD	O
O	O	471	480	terminate	terminate	I-VP	VB	O	3	VMOD	O
O	O	481	486	tumor	tumor	B-NP	NN	B-protein	9	NMOD	B-protein
O	O	487	495	necrosis	necrosis	I-NP	NN	I-protein	9	NMOD	I-protein
O	O	496	502	factor	factor	I-NP	NN	I-protein	14	NMOD	I-protein
O	O	502	503	-	-	B-VP	HYPH	O	9	P	O
O	O	503	510	induced	induce	B-NP	VBN	O	14	NMOD	O
T8	B-Entity	511	513	NF	NF	I-NP	NN	B-protein	14	NMOD	B-protein
T8	I-Entity	513	514	-	-	O	HYPH	I-protein	14	P	I-protein
T8	I-Entity	514	520	kappaB	kappaB	B-NP	NN	I-protein	6	OBJ	I-protein
O	O	521	528	binding	bind	B-VP	VBG	O	14	NMOD	O
O	O	529	531	to	to	B-PP	TO	O	15	VMOD	O
O	O	532	535	the	the	B-NP	DT	O	19	NMOD	O
T9	B-Entity	536	544	enhancer	enhancer	I-NP	NN	B-DNA	19	NMOD	B-DNA
T9	I-Entity	545	554	sequences	sequence	I-NP	NNS	I-DNA	16	PMOD	I-DNA
O	O	555	557	in	in	B-PP	IN	O	19	NMOD	O
O	O	558	560	U1	U1	B-NP	NN	B-cell_line	23	NMOD	B-cell_line
O	O	561	570	monocytic	monocytic	I-NP	JJ	I-cell_line	23	NMOD	I-cell_line
O	O	571	576	cells	cell	I-NP	NNS	I-cell_line	20	PMOD	I-cell_line
O	O	576	577	,	,	O	,	O	6	P	O
O	O	578	583	using	use	B-VP	VBG	O	6	VMOD	O
O	O	584	585	a	a	B-NP	DT	O	28	NMOD	O
O	O	586	591	short	short	I-NP	JJ	O	28	NMOD	O
O	O	592	597	pulse	pulse	I-NP	NN	O	25	OBJ	O
O	O	598	600	of	of	B-PP	IN	O	28	NMOD	O
O	O	601	610	exogenous	exogenous	B-NP	JJ	B-protein	33	NMOD	B-protein
O	O	611	616	tumor	tumor	I-NP	NN	I-protein	33	NMOD	I-protein
O	O	617	625	necrosis	necrosis	I-NP	NN	I-protein	33	NMOD	I-protein
O	O	626	632	factor	factor	I-NP	NN	I-protein	29	PMOD	I-protein
O	O	632	633	.	.	O	.	O	3	P	O

O	O	634	638	This	This	B-NP	DT	O	2	SUB	O
O	O	639	647	resulted	result	B-VP	VBD	O	0	ROOT	O
O	O	648	650	in	in	B-PP	IN	O	2	VMOD	O
O	O	651	662	concomitant	concomitant	B-NP	JJ	O	5	NMOD	O
O	O	663	671	decrease	decrease	I-NP	NN	O	3	PMOD	O
O	O	672	674	in	in	B-PP	IN	O	5	NMOD	O
O	O	675	682	nuclear	nuclear	B-NP	JJ	O	14	NMOD	O
T10	B-Entity	683	685	NF	NF	I-NP	NN	O	14	NMOD	O
T10	I-Entity	685	686	-	-	O	HYPH	O	14	NMOD	O
T10	I-Entity	686	692	kappaB	kappaB	B-NP	NN	B-DNA	11	NMOD	B-DNA
O	O	693	696	DNA	DNA	I-NP	NN	I-DNA	14	NMOD	I-DNA
O	O	696	697	-	-	B-NP	HYPH	O	14	NMOD	O
O	O	697	704	binding	binding	I-NP	NN	O	14	NMOD	O
O	O	705	713	activity	activity	I-NP	NN	O	21	NMOD	O
O	O	714	717	and	and	O	CC	O	21	NMOD	O
T11	B-Entity	718	728	endogenous	endogenous	B-NP	JJ	B-DNA	19	NMOD	B-DNA
T11	I-Entity	729	733	long	long	I-NP	JJ	I-DNA	19	NMOD	I-DNA
T11	I-Entity	734	742	terminal	terminal	I-NP	JJ	I-DNA	19	NMOD	I-DNA
T11	I-Entity	743	749	repeat	repeat	I-NP	NN	I-DNA	21	NMOD	I-DNA
O	O	750	765	transcriptional	transcriptional	I-NP	JJ	O	21	NMOD	O
O	O	766	774	activity	activity	I-NP	NN	O	6	PMOD	O
O	O	774	775	.	.	O	.	O	2	P	O

O	O	776	779	The	The	B-NP	DT	O	2	NMOD	O
O	O	780	786	second	second	I-NP	NN	O	3	SUB	O
O	O	787	790	was	be	B-VP	VBD	O	0	ROOT	O
O	O	791	793	to	to	B-VP	TO	O	5	VMOD	O
O	O	794	802	suppress	suppress	I-VP	VB	O	3	PRD	O
O	O	803	806	the	the	B-NP	DT	O	11	NMOD	O
O	O	807	816	permanent	permanent	I-NP	JJ	O	11	NMOD	O
T12	B-Entity	817	819	NF	NF	I-NP	NN	B-protein	11	NMOD	B-protein
T12	I-Entity	819	820	-	-	B-NP	HYPH	I-protein	11	NMOD	I-protein
T12	I-Entity	820	826	kappaB	kappaB	I-NP	NN	I-protein	11	NMOD	I-protein
O	O	827	840	translocation	translocation	I-NP	NN	O	5	OBJ	O
O	O	841	848	induced	induce	B-VP	VBN	O	11	NMOD	O
O	O	849	851	by	by	B-PP	IN	O	12	VMOD	O
O	O	852	855	HIV	HIV	B-NP	NN	O	17	NMOD	O
O	O	855	856	-	-	B-NP	HYPH	O	17	P	O
O	O	856	857	1	1	I-NP	CD	O	17	NMOD	O
O	O	858	869	replication	replication	I-NP	NN	O	18	NMOD	O
O	O	870	876	itself	itself	B-NP	PRP	O	13	PMOD	O
O	O	877	879	in	in	B-PP	IN	O	5	VMOD	O
O	O	880	891	chronically	chronically	B-NP	RB	B-cell_line	21	AMOD	B-cell_line
O	O	892	900	infected	infected	I-NP	JJ	I-cell_line	23	NMOD	I-cell_line
O	O	901	905	U937	U937	I-NP	NN	I-cell_line	23	NMOD	I-cell_line
O	O	906	911	cells	cell	I-NP	NNS	I-cell_line	19	PMOD	I-cell_line
O	O	911	912	,	,	O	,	O	5	P	O
O	O	913	918	using	use	B-VP	VBG	O	5	VMOD	O
O	O	919	920	a	a	B-NP	DT	O	29	NMOD	O
O	O	921	929	specific	specific	I-NP	JJ	O	29	NMOD	O
O	O	930	940	proteasome	proteasome	I-NP	NN	B-protein	29	NMOD	B-protein
O	O	941	950	inhibitor	inhibitor	I-NP	NN	O	25	OBJ	O
O	O	951	952	(	(	O	(	O	36	DEP	O
O	O	952	953	Z	Z	B-NP	NN	B-protein	35	NMOD	B-protein
O	O	953	954	-	-	B-NP	HYPH	O	35	P	O
O	O	954	957	LLL	LLL	I-NP	NN	B-protein	35	NMOD	B-protein
O	O	957	958	-	-	B-NP	HYPH	I-protein	35	P	I-protein
O	O	958	959	H	H	I-NP	NN	I-protein	36	DEP	I-protein
O	O	959	960	)	)	O	)	O	29	NMOD	O
O	O	960	961	.	.	O	.	O	3	P	O

O	O	962	964	As	As	B-ADVP	RB	O	3	AMOD	O
O	O	965	970	early	early	I-ADVP	RB	O	3	AMOD	O
O	O	971	973	as	as	B-PP	IN	O	17	VMOD	O
O	O	974	975	2	2	B-NP	CD	O	3	AMOD	O
O	O	976	977	h	h	I-NP	NN	O	3	PMOD	O
O	O	978	983	after	after	B-PP	IN	O	3	PMOD	O
O	O	984	992	addition	addition	B-NP	NN	O	3	PMOD	O
O	O	993	995	of	of	B-PP	IN	O	7	NMOD	O
O	O	996	999	the	the	B-NP	DT	O	10	NMOD	O
O	O	1000	1009	inhibitor	inhibitor	I-NP	NN	O	8	PMOD	O
O	O	1010	1012	to	to	B-PP	TO	O	7	NMOD	O
O	O	1013	1016	the	the	B-NP	DT	O	14	NMOD	O
O	O	1017	1024	culture	culture	I-NP	NN	O	14	NMOD	O
O	O	1025	1031	medium	medium	I-NP	NN	O	11	PMOD	O
O	O	1031	1032	,	,	O	,	O	17	P	O
O	O	1033	1038	there	there	B-NP	EX	O	17	SUB	O
O	O	1039	1042	was	be	B-VP	VBD	O	0	ROOT	O
O	O	1043	1045	an	an	B-NP	DT	O	19	NMOD	O
O	O	1046	1056	inhibition	inhibition	I-NP	NN	O	17	PRD	O
O	O	1057	1059	of	of	B-PP	IN	O	19	NMOD	O
O	O	1060	1064	both	both	O	CC	O	23	NMOD	O
O	O	1065	1077	constitutive	constitutive	B-NP	JJ	O	23	NMOD	O
O	O	1078	1088	activation	activation	I-NP	NN	O	33	NMOD	O
O	O	1089	1091	of	of	B-PP	IN	O	23	NMOD	O
T13	B-Entity	1092	1094	NF	NF	B-NP	NN	B-protein	27	NMOD	B-protein
T13	I-Entity	1094	1095	-	-	B-NP	HYPH	I-protein	27	NMOD	I-protein
T13	I-Entity	1095	1101	kappaB	kappaB	I-NP	NN	I-protein	24	PMOD	I-protein
O	O	1102	1105	and	and	I-NP	CC	O	33	NMOD	O
O	O	1106	1109	HIV	HIV	I-NP	NN	O	33	NMOD	O
O	O	1109	1110	-	-	B-NP	HYPH	O	33	NMOD	O
O	O	1110	1111	1	1	I-NP	CD	O	33	NMOD	O
O	O	1112	1118	genome	genome	I-NP	NN	O	33	NMOD	O
O	O	1119	1129	expression	expression	I-NP	NN	O	20	PMOD	O
O	O	1129	1130	.	.	O	.	O	17	P	O

O	O	1131	1134	The	The	B-NP	DT	O	3	NMOD	O
O	O	1135	1140	third	third	I-NP	JJ	O	3	NMOD	O
O	O	1141	1149	approach	approach	I-NP	NN	O	4	SUB	O
O	O	1150	1153	was	be	B-VP	VBD	O	0	ROOT	O
O	O	1154	1156	to	to	B-VP	TO	O	6	VMOD	O
O	O	1157	1164	monitor	monitor	I-VP	VB	O	4	PRD	O
O	O	1165	1168	the	the	B-NP	DT	O	9	NMOD	O
O	O	1169	1180	replication	replication	I-NP	NN	O	9	NMOD	O
O	O	1181	1191	competence	competence	I-NP	NN	O	19	NMOD	O
O	O	1192	1194	in	in	B-PP	IN	O	9	NMOD	O
O	O	1195	1199	U937	U937	B-NP	NN	B-cell_line	12	NMOD	B-cell_line
O	O	1200	1205	cells	cell	I-NP	NNS	I-cell_line	10	PMOD	I-cell_line
O	O	1206	1208	of	of	B-PP	IN	O	12	NMOD	O
O	O	1209	1211	an	an	B-NP	DT	O	16	NMOD	O
O	O	1212	1222	infectious	infectious	I-NP	JJ	O	16	NMOD	O
O	O	1223	1226	HIV	HIV	I-NP	NN	O	13	PMOD	O
O	O	1226	1227	-	-	B-NP	HYPH	O	19	NMOD	O
O	O	1227	1228	1	1	I-NP	CD	O	19	NMOD	O
O	O	1229	1237	provirus	provirus	I-NP	NN	O	6	OBJ	O
O	O	1238	1246	carrying	carry	B-VP	VBG	O	19	NMOD	O
O	O	1247	1252	point	point	B-NP	NN	O	22	NMOD	O
O	O	1253	1262	mutations	mutation	I-NP	NNS	O	20	OBJ	O
O	O	1263	1265	in	in	B-PP	IN	O	20	VMOD	O
O	O	1266	1269	the	the	B-NP	DT	O	28	NMOD	O
T14	B-Entity	1270	1276	kappaB	kappaB	I-NP	NN	B-DNA	28	NMOD	B-DNA
T14	I-Entity	1276	1277	-	-	B-NP	HYPH	I-DNA	28	NMOD	I-DNA
T14	I-Entity	1277	1287	responsive	responsive	I-NP	JJ	I-DNA	28	NMOD	I-DNA
T14	I-Entity	1288	1296	elements	element	I-NP	NNS	I-DNA	23	PMOD	I-DNA
O	O	1297	1299	of	of	B-PP	IN	O	28	NMOD	O
O	O	1300	1304	both	both	B-NP	CC	O	33	NMOD	O
T15	B-Entity	1305	1309	long	long	I-NP	JJ	B-DNA	33	NMOD	B-DNA
T15	I-Entity	1310	1318	terminal	terminal	I-NP	JJ	I-DNA	33	NMOD	I-DNA
T15	I-Entity	1319	1326	repeats	repeat	I-NP	NNS	I-DNA	29	PMOD	I-DNA
O	O	1326	1327	.	.	O	.	O	4	P	O

O	O	1328	1336	Compared	Compare	B-PP	VBN	O	12	VMOD	O
O	O	1337	1341	with	with	B-PP	IN	O	1	PMOD	O
O	O	1342	1345	its	its	B-NP	PRP$	O	7	NMOD	O
O	O	1346	1350	wild	wild	I-NP	JJ	B-protein	7	NMOD	B-protein
O	O	1350	1351	-	-	I-NP	HYPH	I-protein	7	NMOD	I-protein
O	O	1351	1355	type	type	I-NP	NN	I-protein	7	NMOD	I-protein
O	O	1356	1367	counterpart	counterpart	I-NP	NN	I-protein	2	PMOD	I-protein
O	O	1367	1368	,	,	O	,	O	12	P	O
O	O	1369	1373	this	this	B-NP	DT	O	11	NMOD	O
O	O	1374	1381	mutated	mutate	I-NP	VBN	O	11	NMOD	O
O	O	1382	1390	provirus	provirus	I-NP	NN	O	12	SUB	O
O	O	1391	1397	showed	show	B-VP	VBD	O	0	ROOT	O
O	O	1398	1399	a	a	B-NP	DT	O	21	NMOD	O
O	O	1400	1410	profoundly	profoundly	I-NP	RB	O	15	AMOD	O
O	O	1411	1420	decreased	decrease	I-NP	VBN	O	21	NMOD	O
O	O	1420	1421	,	,	I-NP	,	O	21	P	O
O	O	1422	1423	Z	Z	I-NP	NN	B-protein	21	NMOD	B-protein
O	O	1423	1424	-	-	I-NP	HYPH	O	21	P	O
O	O	1424	1427	LLL	LLL	I-NP	NN	B-protein	21	NMOD	B-protein
O	O	1427	1428	-	-	B-NP	HYPH	I-protein	21	P	I-protein
O	O	1428	1429	H	H	I-NP	NN	I-protein	27	NMOD	I-protein
O	O	1429	1430	-	-	B-NP	HYPH	O	27	P	O
O	O	1430	1441	insensitive	insensitive	I-NP	JJ	O	26	AMOD	O
O	O	1442	1457	transcriptional	transcriptional	I-NP	JJ	O	26	AMOD	O
O	O	1458	1461	and	and	I-NP	CC	O	26	AMOD	O
O	O	1462	1473	replicative	replicative	I-NP	JJ	O	27	NMOD	O
O	O	1474	1482	activity	activity	I-NP	NN	O	12	OBJ	O
O	O	1483	1485	in	in	B-PP	IN	O	27	NMOD	O
O	O	1486	1490	U937	U937	B-NP	NN	B-cell_line	30	NMOD	B-cell_line
O	O	1491	1500	monocytes	monocyte	I-NP	NNS	I-cell_line	28	PMOD	I-cell_line
O	O	1500	1501	.	.	O	.	O	12	P	O

O	O	1502	1510	Together	Together	B-ADVP	RB	O	5	VMOD	O
O	O	1510	1511	,	,	O	,	O	5	P	O
O	O	1512	1515	our	our	B-NP	PRP$	O	4	NMOD	O
O	O	1516	1523	results	result	I-NP	NNS	O	5	SUB	O
O	O	1524	1532	indicate	indicate	B-VP	VBP	O	0	ROOT	O
O	O	1533	1537	that	that	B-SBAR	IN	O	5	VMOD	O
O	O	1538	1547	occupancy	occupancy	B-NP	NN	O	22	SUB	O
O	O	1548	1550	of	of	B-PP	IN	O	7	NMOD	O
O	O	1551	1554	the	the	B-NP	DT	O	11	NMOD	O
T16	B-Entity	1555	1560	viral	viral	I-NP	JJ	B-DNA	11	NMOD	B-DNA
T16	I-Entity	1561	1569	enhancer	enhancer	I-NP	NN	I-DNA	8	PMOD	I-DNA
O	O	1570	1572	by	by	B-PP	IN	O	7	NMOD	O
O	O	1573	1575	NF	NF	B-NP	NN	B-protein	15	NMOD	B-protein
O	O	1575	1576	-	-	O	HYPH	I-protein	15	NMOD	I-protein
O	O	1576	1582	kappaB	kappaB	B-NP	NN	I-protein	21	NMOD	I-protein
O	O	1583	1584	(	(	O	(	O	20	DEP	O
T1,T17	B-Protein,B-Entity	1584	1587	p50	p50	B-NP	NN	B-protein	19	NMOD	B-protein
T17	I-Entity	1587	1588	/	/	O	SYM	O	19	P	O
T2,T17	B-Protein,I-Entity	1588	1591	p65	p65	B-NP	NN	B-protein	20	DEP	B-protein
O	O	1591	1592	)	)	O	)	O	15	NMOD	O
T18	B-Entity	1593	1605	heterodimers	heterodimer	B-NP	NNS	O	12	PMOD	O
O	O	1606	1608	is	be	B-VP	VBZ	O	6	SBAR	O
O	O	1609	1617	required	require	I-VP	VBN	O	22	VC	O
O	O	1618	1621	for	for	B-PP	IN	O	23	VMOD	O
O	O	1622	1629	ongoing	ongoing	B-NP	JJ	O	26	NMOD	O
O	O	1630	1643	transcription	transcription	I-NP	NN	O	24	PMOD	O
O	O	1644	1646	of	of	B-PP	IN	O	26	NMOD	O
O	O	1647	1657	integrated	integrate	B-NP	VBN	O	30	NMOD	O
T19	B-Entity	1658	1661	HIV	HIV	I-NP	NN	O	30	NMOD	O
T19	I-Entity	1662	1670	provirus	provirus	I-NP	NN	O	27	PMOD	O
O	O	1671	1673	in	in	B-PP	IN	O	26	NMOD	O
O	O	1674	1683	monocytes	monocyte	B-NP	NNS	B-cell_type	31	PMOD	B-cell_type
O	O	1683	1684	,	,	O	,	O	23	P	O
O	O	1685	1689	even	even	B-ADVP	RB	O	35	PMOD	O
O	O	1690	1692	in	in	B-PP	IN	O	23	VMOD	O
O	O	1693	1698	cells	cell	B-NP	NNS	O	35	PMOD	O
O	O	1699	1710	chronically	chronically	B-ADJP	RB	O	38	VMOD	O
O	O	1711	1719	infected	infected	I-ADJP	JJ	O	36	NMOD	O
O	O	1720	1723	and	and	O	CC	O	38	VMOD	O
O	O	1724	1735	permanently	permanently	B-VP	RB	O	38	VMOD	O
O	O	1736	1745	producing	produce	I-VP	VBG	O	38	VMOD	O
O	O	1746	1756	functional	functional	B-NP	JJ	O	41	OBJ	O
O	O	1757	1760	HIV	HIV	I-NP	NN	B-protein	45	NMOD	B-protein
T3	B-Protein	1761	1764	Tat	Tat	I-NP	NN	I-protein	45	NMOD	I-protein
O	O	1765	1772	protein	protein	I-NP	NN	I-protein	42	NMOD	I-protein
O	O	1772	1773	.	.	O	.	O	5	P	O

O	O	1774	1778	Thus	Thus	B-ADVP	RB	O	15	VMOD	O
O	O	1778	1779	,	,	O	,	O	15	P	O
O	O	1780	1783	the	the	B-NP	DT	O	4	NMOD	O
O	O	1784	1791	ability	ability	I-NP	NN	O	15	SUB	O
O	O	1792	1794	of	of	B-PP	IN	O	4	NMOD	O
O	O	1795	1798	HIV	HIV	B-NP	NN	O	9	NMOD	O
O	O	1798	1799	-	-	B-NP	HYPH	O	9	NMOD	O
O	O	1799	1800	1	1	I-NP	CD	O	9	NMOD	O
O	O	1801	1812	replication	replication	I-NP	NN	O	5	PMOD	O
O	O	1813	1815	to	to	B-VP	TO	O	11	VMOD	O
O	O	1816	1824	activate	activate	I-VP	VB	O	4	NMOD	O
T20	B-Entity	1825	1827	NF	NF	B-NP	NN	B-protein	14	NMOD	B-protein
T20	I-Entity	1827	1828	-	-	O	HYPH	I-protein	14	NMOD	I-protein
T20	I-Entity	1828	1834	kappaB	kappaB	B-NP	NN	I-protein	11	OBJ	I-protein
O	O	1835	1837	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	1838	1845	crucial	crucial	B-ADJP	JJ	O	15	PRD	O
O	O	1846	1848	to	to	B-PP	TO	O	16	AMOD	O
O	O	1849	1852	the	the	B-NP	DT	O	20	NMOD	O
O	O	1853	1860	intense	intense	I-NP	JJ	O	20	NMOD	O
O	O	1861	1865	self	self	I-NP	NN	O	24	NMOD	O
O	O	1865	1866	-	-	O	HYPH	O	20	P	O
O	O	1866	1877	perpetuated	perpetuate	B-VP	VBN	O	20	AMOD	O
O	O	1878	1883	viral	viral	B-NP	JJ	O	20	NMOD	O
O	O	1884	1897	transcription	transcription	I-NP	NN	O	17	PMOD	O
O	O	1898	1906	observed	observe	B-VP	VBN	O	24	NMOD	O
O	O	1907	1909	in	in	B-PP	IN	O	25	VMOD	O
O	O	1910	1915	cells	cell	B-NP	NNS	O	26	PMOD	O
O	O	1916	1918	of	of	B-PP	IN	O	27	NMOD	O
O	O	1919	1922	the	the	B-NP	DT	O	31	NMOD	O
O	O	1923	1932	monocytic	monocytic	I-NP	JJ	B-cell_type	31	NMOD	B-cell_type
O	O	1933	1940	lineage	lineage	I-NP	NN	I-cell_type	28	PMOD	I-cell_type
O	O	1940	1941	.	.	O	.	O	15	P	O
